This website uses cookies to improve your experience. Learn more about cookies and how to manage them.


David Webb.jpgProfessor David Webb, President
David trained in medicine in London, started research training at the MRC Blood Pressure Unit in Glasgow, and completed research and clinical training in pharmacology & therapeutics in John Kelly‘s department at St George’s Hospital in London, working with Dr Joe Collier. His main interests are the pathophysiology and treatment of hypertension and chronic kidney disease, particularly focusing on endothelial function, and in the promotion of safe and effective prescribing. He is involved in running two Scottish translational medicine and therapeutics (TMAT) initiatives, supported by the Wellcome Trust and MRC.

Professor Stephen Hill, President Elect
Steve studied Pharmacology in Bristol and then undertook PhD studies in the Department of Pharmacology in Cambridge.  After postdoctoral studies in Cambridge he was appointed to a lectureship in the Department of Pharmacy at the University of Nottingham in 1981. Steve is currently Professor of Molecular Pharmacology in the School of Life Sciences in Nottingham and an Adjunct Professor at the University of Western Australia. His research interests are the molecular pharmacology of G Protein-coupled receptors and the study of single ligand-receptor interactions in membrane microdomains using fluorescence correlation spectroscopy.

Professor Robin Plevin, Honorary Treasurer
Robin did his undergraduate degree in pharmacology at Edinburgh and completed his PhD at the University of Southampton and MS&D (Terlings Park). In 1991 he became a lecturer at the University of Strathclyde within the department of Physiology and Pharmacology headed by Professor Bill Bowman. His current interests are in the understanding and targeting of key cell signalling pathways for the development of new anticancer and anti-arthritic drugs. Robin is currently the Head of the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde and a fellow of the BPS.

Professor Emma Baker, Elected Trustee (Clinical)
Professor Emma Baker trained in medicine in Edinburgh and did her PhD in Manchester before completing training in Clinical Pharmacology and Therapeutics in London with Joe Collier. She is currently Professor of Clinical Pharmacology at St George's, where she conducts experimental medicine studies and investigator-led clinical trials relating to COPD exacerbations and co-morbidity. She has a strong educational background, being a recipient of a national teaching fellowship and is an author of two recent textbooks designed to help students develop prescribing knowledge and skills. Her NHS work includes medicines management and educational supervision of clinical pharmacology trainees.

Antony Galione.jpgProfessor Antony Galione, Co-Chair of CHOPT
Antony obtained a degree in Pharmacology from the University of Cambridge, and a PhD there under the supervision of Sir Michael Berridge. He has been at the Department of Pharmacology at the University of Oxford since 1991, and was elected to the Chair of Pharmacology in 2006 and has also been Head of Department since then. His research interests are in the field of calcium signalling, and in particular the role of calcium mobilizing messengers such as IP3, cyclic ADP-ribose and NAADP in receptor-effector coupling. He is a Wellcome Trust Senior Investigator and a Fellow of the Academy of Medical Sciences.

Charles Gloor, Appointed Trustee (Business)
Charles Gloor is a founding partner of birgli, an interim management and consulting company providing services and support to pharmaceutical companies, wholesalers, pharmacy chains & banner groups, and investors in the sector. Nominated by the European Bank for Reconstruction & Development (EBRD), he is currently a NED of Monos, the leading pharmaceutical wholesaler, retailer, and manufacturer in Mongolia. Prior to founding birgli in 2006, Charles established & led AVS Health (now Movianto) providing distribution and marketing services to leading healthcare companies throughout Europe. He previously established Zuellig Pharma as Vietnam’s largest foreign pharmaceutical distributor and marketing services provider.

Richard Green.jpgProfessor Richard Green, Elected Trustee
Richard is currently Honorary Professor of Neuropharmacology at the University of Nottingham. His PhD was with Gerald Curzon and following two years at NIMH, Washington DC he joined David Grahame-Smith at the MRC Clinical Pharmacology Unit in Oxford, becoming Assistant Director in 1981. In 1986 he was appointed Director of the new Astra Neuroscience Research Unit in London, subsequently becoming Director, Global Discovery CNS & Pain Control for AstraZeneca. After retiring from AstraZ eneca he has continued psychopharmacology research in Nottingham. He is a former President of the International Society for Serotonin Research and a President Emeritus of the British Pharmacological Society.

Emma Mason.jpgEmma Mason, Appointed Trustee (External Relations)
Emma graduated from Southampton University with a BA in Roman and Hellenic studies. She obtained a post-graduate diploma in journalism at City University and then worked as a reporter for regional and national newspapers. She moved into public relations, joining the Imperial Cancer Research Fund (now part of Cancer Research UK) before becoming a freelance media relations consultant specialising in the medical sciences. During the past couple of decades her clients have included a wide range of organisations, such as Oxford University Press, the National Translational Cancer Research Network and Queen Mary University of London, and European medical sciences societies and their conferences, such as those for cancer, cardiology, human reproduction and embryology, respiratory diseases, and neuroscience.

Alyn Morice.jpgProfessor Alyn Morice, Co-Chair of CHOPT
Alyn qualified at Cambridge University and after House jobs in London undertook research (MD) into the pharmacology of asthma at St Mary’s Hospital. As Clinical Lecturer at Addenbrooke’s Hospital he developed his interest in cough, demonstrating cough hypersensitivity caused by ACE inhibitors. In 1989 he was appointed as Senior Lecturer in Sheffield developing a Pulmonary Vascular service and the first UK Cough Clinic. In 1998 he was appointed to the Foundation Chair in Respiratory Medicine in Hull University (now part of the Hull York Medical School). The Cough Clinic has become the largest centre within Europe with an international pattern of referral. Unique investigational strategies provide diagnosis and treatment advances which are incorporated into national and international guideline documents. He has led the European Respiratory Society and British Thoracic Society Taskforces on Cough.

Aidan Seeley, Appointed Trustee (Young Pharmacologist)
Aidan graduated in 2015 from the University of Aberdeen in Biomedical Sciences (Pharmacology), where he was awarded the Pharmacology Prize. While studying in Aberdeen, Aidan established the Aberdeen Medical Science Network, a student-run organisation aimed at promoting networking between staff and students, for which he was awarded the BPS Student Contribution to Pharmacology Prize. Aidan is currently at Queen’s University Belfast working with Dr Emma Evergren & Dr Daniel Longley for his PhD, which focuses on receptor mediated endocytosis in cancer cells. 

Dr Malcolm Skingle, Elected Trustee (Industry)
Malcolm Skingle has a BSc in Pharmacology/Biochemistry and a PhD in Neuropharmacology.  He has worked in the pharmaceutical industry for more than 40 years and has gained a wide breadth of experience in the management of research activities.  Part of his former role as a research leader in a Neuropharmacology department involved co-supervising collaborations with academics in the UK, Europe and USA.  He has more than 60 publications including articles on the interface between industry and academia. Malcolm has also been awarded a CBE in the 2009 Queen’s Birthday Honours List in recognition of his contribution to the pharmaceutical industry as well as an Honorary Professorship from the College of Medical and Dental Sciences at the University of Birmingham and an honorary DSc from the University of Hertfordshire and honorary degree from the University of Dundee and a fellowship from Imperial College London medical faculty.  Malcolm was elected as a Fellow into the Faculty of Medicine at Imperial College London in 2011.

Dr Ivor Williams, Elected Trustee (General)
Ivor studied Pharmacology at Chelsea College . He joined Sir John Vane’s group at the Royal College of Surgeons in 1968 working on the involvement of prostaglandins in uterine contractility and gaining his doctorate. In 1972 he moved to Bristol for post-doctoral work funded by the Wellcome Trust. In 1974 he took up a lecturership in Pharmacology at Bath University, becoming Senior Lecturer in 1980. His research interests focussed on vasoactive mediators and he devised a functional pharmacology teaching syllabus incorporating such elements which remains in place today. He became Novartis Teaching Fellow in 2006. A BPS member since 1972 he has served as a Journal editor and undertook a survey on behalf of the BPS for the Biosciences Federation and the ABPI in 2008 on “Sustaining the supply of In Vivo skills in the 21st century”. Ivor was elected an Honorary Fellow of the BPS in 2015 and is also the Society’s Events Photographer.

Iain Greenwood.jpgProfessor Iain Greenwood, Vice President - Policy & Public Engagement (non-Trustee)
Iain obtained a First Class Honours Degree in Physiology and Pharmacology from the University of Hertfordshire in 1990 and completed a PhD in Physiology & Pharmacology from the University of Manchester in 1993 working in the Smooth Muscle Research Group under the supervision of Professor AH Weston. After a post-doctoral position at St George’s Hospital Medical School he was awarded a four-year Wellcome Trust Career Development Fellowship and spent part of it working with Professor Normand Leblanc at the Montreal Heart Institute. In 2001 he suspended his Fellowship to work with Professor Burt Horowitz in the Department of Physiology and Cell Biology at the University of Nevada Medical School, Reno, USA. After various faculty positions Iain Greenwood was appointed Professor of Vascular Pharmacology at St George’s, London in 2013. He also holds a visiting professorship in the Department of Biomedical Sciences (Heart and Circulatory Research Section) at the University of Copenhagen, Denmark following a long term collaboration with Professor Søren P Olesen. His main research interests are ion channel function in vascular and non-vascular physiology and the targeting of ion channels as therapeutic agents.

Graeme Henderson.jpgProfessor Graeme Henderson, Vice President - Publications (non-Trustee)
Graeme trained in Aberdeen under the supervision of Professor Hans Kosterlitz and Professor John Hughes. He was an Assistant Professor at Loyola University in Chicago and a lecturer at the University of Cambridge before moving to the University of Bristol where he is Professor of Pharmacology. His research interests lie in the mechanism of action of opioid drugs and how the body adapts to their presence resulting in the development of tolerance and physical dependence. Graeme is a co-author of Rang & Dale’s Pharmacology  8th Edition.

Barbara McDermott.jpgProfessor Barbara McDermott, Vice President - Meetings (non-Trustee )
Barbara has been at Queen's University Belfast for most of her education and career, although has spent time away, firstly working in industry in Sheffield and later as a Postdoctoral Fellow in Bradford. Since appointment to an academic position at QUB in 1985, she has worked in other laboratories through exchange programmes with Germany and Japan, and during sabbatical terms in Canada and the United States. Research activities have focused on autocrine/paracrine control of cardiovascular dysfunction with special emphasis on the pharmacology of important peptide mediators, such as angiotensin II, endothelins, neuropeptide Y and the calcitonin gene-related peptide family. The contribution of oxidative stress to myocardial remodelling and interaction with peptide signalling pathways is of specific interest. Now Professor Emeritus, Barbara fulfils a further role in promoting gender equality in scientific careers and study of sex-gender in pursuit of research excellence. 

Ian McFadzean.jpgProfessor Ian McFadzean, Vice President - Academic Development (non-Trustee)
Ian graduated with a BSc in pharmacy from the University of Strathclyde before studying towards a PhD in pharmacology at the University of Cambridge under the supervision of Professors Ray Hill and Graeme Henderson. After a post-doc at University College London with Professor David Brown he gained a lectureship in pharmacology at King’s College London. He is now a Senior Lecturer in pharmacology at King’s and Dean of Undergraduate Studies within the School of Biomedical Sciences. He is interested in all aspects of university education and training in the biomedical sciences whilst his research focuses on calcium entry mechanisms in smooth muscle and other cells.

Professor Sir Munir Pirmohamed, Vice President - Clinical (non-Trustee)
Munir is the NHS Chair of Pharmacogenetics in the UK at the University of Liverpool, and is Director of the Wolfson Centre for Personalised Medicine. He is a Commissioner on Human Medicines and is the Chair of its Pharmacovigilance Expert Advisory Group. He is also an inaugural NIHR Senior Investigator. His research focuses on individual variability in drug response with a view to evaluating the mechanisms, and identifying strategies to personalise medicines in order to optimise drug efficacy and minimise toxicity. The work spans the whole spectrum from discovery to implementation with the aim of developing the evidence base that can move discoveries from the lab to the clinic.